importantSYS.SOURCE: PopVax Chronicles• 2026-10-10T15:10:24Z

Phase 1 Clinical Trial Initiated for PopVax's Broadly Protective COVID-19 Vaccine PVX-001

#mrna #vaccine #clinical trial #open source #biotechnology

PopVax's PVX-001, an mRNA-encoded virus-like particle (VLP) vaccine, has initiated a Phase 1 trial in Melbourne to assess safety and immunogenicity. The open-source vaccine aims to provide broad protection against SARS-CoV-2 variants through a novel manufacturing approach.

Read original article

*** END OF TRANSMISSION ***

> APPLE'S STRATEGIC MOVE: HIRING HUXE TEAM AND LICENSING AI TECHNOLOGY FOR PERSONALIZED PODCASTS > TAKESHI'S CASTLE: JAPANESE TELEVISION GAME SHOW AND INTERNATIONAL ADAPTATIONS > NVIDIA EXPLORES ACQUISITION OF US OPEN-SOURCE AI STARTUP REFLECTION AI > AI-DRIVEN WEB BROWSER PORTS OF CLASSIC GAMES DEMONSTRATE HIGH FUNCTIONALITY > DUCKDB 2.0 PERFORMANCE ENHANCEMENTS: ASYNC I/O AND RECURSIVE CTE OPTIMIZATIONS > PETRA POWER ADVANCES SOLID OXIDE FUEL CELL TECHNOLOGY FOR DATA CENTERS AND DEFENSE APPLICATIONS > CLOUDFLARE ACQUIRES DENO TO ENHANCE WORKERS PROGRAMMING MODEL > DONALD KNUTH'S ERROR REWARD CHECK FOR COMPUTER MODERN TYPEFACES > THE DOMINANCE OF PROTEIN IN BIOLOGICAL SYSTEMS > PHASE 1 CLINICAL TRIAL INITIATED FOR POPVAX'S BROADLY PROTECTIVE COVID-19 VACCINE PVX-001> APPLE'S STRATEGIC MOVE: HIRING HUXE TEAM AND LICENSING AI TECHNOLOGY FOR PERSONALIZED PODCASTS > TAKESHI'S CASTLE: JAPANESE TELEVISION GAME SHOW AND INTERNATIONAL ADAPTATIONS > NVIDIA EXPLORES ACQUISITION OF US OPEN-SOURCE AI STARTUP REFLECTION AI > AI-DRIVEN WEB BROWSER PORTS OF CLASSIC GAMES DEMONSTRATE HIGH FUNCTIONALITY > DUCKDB 2.0 PERFORMANCE ENHANCEMENTS: ASYNC I/O AND RECURSIVE CTE OPTIMIZATIONS > PETRA POWER ADVANCES SOLID OXIDE FUEL CELL TECHNOLOGY FOR DATA CENTERS AND DEFENSE APPLICATIONS > CLOUDFLARE ACQUIRES DENO TO ENHANCE WORKERS PROGRAMMING MODEL > DONALD KNUTH'S ERROR REWARD CHECK FOR COMPUTER MODERN TYPEFACES > THE DOMINANCE OF PROTEIN IN BIOLOGICAL SYSTEMS > PHASE 1 CLINICAL TRIAL INITIATED FOR POPVAX'S BROADLY PROTECTIVE COVID-19 VACCINE PVX-001